- |||||||||| KB195 / Kaleido Biosci
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: UNLOCKED: A Phase 2, Open-label Trial With KB195 in Subjects With a Urea Cycle Disorder (clinicaltrials.gov) - Jan 25, 2022 P2, N=13, Terminated, N=24 --> 13 | Trial completion date: Nov 2021 --> Mar 2021 | Recruiting --> Terminated | Trial primary completion date: Oct 2021 --> Feb 2021; Kaleido Biosciences, Inc. closed the K020-218 trial due to business reasons, and not due to any safety concerns.
|